Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenesis is the physiological process by which new blood vessels form from pre-existing vessels. This process is essential for normal growth, development, wound healing, and tissue regeneration. However, it also plays a critical role in various diseases, including cancer, where tumors stimulate angiogenesis to secure a blood supply. Targeting angiogenesis has become an important therapeutic strategy, particularly in cancer therapy, with angiogenesis inhibitors used to starve tumors.
Angiogenesis inhibitors block the formation of new blood vessels, depriving tumors of nutrients and oxygen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis.